stannic oxide has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, A; Cao, Y; Hu, L; Liu, X; Liu, Y; Lv, H; Shang, W; Wu, C | 1 |
| Kumar, SH; Madhumitha, G; Roopan, SM; Suthindhiran, K | 1 |
2 other study(ies) available for stannic oxide and Liver Neoplasms
| Article | Year |
|---|---|
Folate-Functionalized Mesoporous Hollow SnO
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Humans; Liver Neoplasms; Mice; Nanofibers; Nanoparticles; Paclitaxel; Tin Compounds | 2018 |
Biogenic-production of SnO2 nanoparticles and its cytotoxic effect against hepatocellular carcinoma cell line (HepG2).
Topics: Annona; Carcinoma, Hepatocellular; Cell Death; Cell Line, Tumor; Cell Shape; Crystallization; Humans; Liver Neoplasms; Metal Nanoparticles; Nanoparticles; Particle Size; Plant Extracts; Spectrophotometry, Ultraviolet; Tin Compounds; X-Ray Diffraction | 2015 |